Health Catalyst (HCAT) EPS (Weighted Average and Diluted) (2019 - 2025)
Health Catalyst (HCAT) has disclosed EPS (Weighted Average and Diluted) for 7 consecutive years, with -$0.31 as the latest value for Q3 2025.
- For the quarter ending Q3 2025, EPS (Weighted Average and Diluted) fell 29.17% year-over-year to -$0.31, compared with a TTM value of -$1.58 through Sep 2025, down 17.91%, and an annual FY2024 reading of -$1.15, up 44.98% over the prior year.
- EPS (Weighted Average and Diluted) was -$0.31 for Q3 2025 at Health Catalyst, up from -$0.59 in the prior quarter.
- Across five years, EPS (Weighted Average and Diluted) topped out at -$0.23 in Q2 2024 and bottomed at -$0.96 in Q4 2021.
- Average EPS (Weighted Average and Diluted) over 5 years is -$0.55, with a median of -$0.58 recorded in 2023.
- The sharpest move saw EPS (Weighted Average and Diluted) surged 60.34% in 2024, then plummeted 156.52% in 2025.
- Year by year, EPS (Weighted Average and Diluted) stood at -$0.96 in 2021, then soared by 31.25% to -$0.66 in 2022, then increased by 21.21% to -$0.52 in 2023, then soared by 36.54% to -$0.33 in 2024, then rose by 6.06% to -$0.31 in 2025.
- Business Quant data shows EPS (Weighted Average and Diluted) for HCAT at -$0.31 in Q3 2025, -$0.59 in Q2 2025, and -$0.35 in Q1 2025.